Alpha Tau Medical Ltd.
NASDAQ:DRTSBiotechnology
+$0.04 today
- Market cap
- $1.11B
- Beta
- 1.20
- P/E (TTM)
- -15.2
- EPS (TTM)
- -$0.63
Volume 0.64M
Average 0.69M
DRTS Other Working Capital
Cash effect of changes in other operating assets and liabilities.
Alpha Tau Medical Ltd.NASDAQ: DRTS
Other Working Capital · Q4 FY2025 · quarter ended Dec 2025
Other working capital outflow grows to $1.95M
Q4 FY2025 other working capital was $1.95M, compared with $0 a year earlier. Trailing-twelve-month other working capital was $1.95M.
Context
- Other working capital increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other working capital holds near $1.95M or moves back toward the trailing-twelve-month quarterly average of $488.5K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Working Capital history
USD · from the cash flow
- Latest · FY2025
- 1.95M USD
- Year-over-year change
- +862.6%
- 4-year CAGR
- +54.2%
| Period | Period end | Other Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.95M | +862.6% |
| FY2024 | 2024-12-31 | 203K | -85.0% |
| FY2023 | 2023-12-31 | 1.35M | +356.0% |
| FY2022 | 2022-12-31 | (527K) | -252.3% |
| FY2021 | 2021-12-31 | 346K | — |
Other Working Capital vs competitors
How DRTS compares with its peers on the latest reported figures
- DRTS's LTM Dec 2025 other working capital of $1.95M is the 2nd largest of the 3 companies compared; the peer median is $1.45M.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| FY2025 | $4.22M | -107.1% | +54.8% | 65.0% | |
| LTM Dec 2025 | $1.95M | — | — | — | |
| LTM Mar 2026 | $1.31M | +156.9% | — | 212.5% | |
| Peer median (excluding DRTS) | $1.45M | +24.9% | +54.8% | 138.7% | |
Competitors are the stored peer set for DRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.27M) | (33.76M) | (29.16M) | (31.75M) | (42.63M) |
| Depreciation & Amortization | 776K | 979K | 1.07M | 1.1M | 1.23M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 812K | 6.75M | 7.93M | 9.92M | 0 |
| Change in Working Capital | 585K | (307K) | 2.49M | 1.17M | 2.29M |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 239K | 220K | 1.14M | 965K | 337K |
| Other Working Capital | 346K | (527K) | 1.35M | 203K | 1.95M |
| Other Non-Cash Items | 13.29M | 2.46M | (293K) | (219K) | 12.42M |
| Operating Cash Flow | (11.81M) | (23.88M) | (17.96M) | (19.78M) | (26.68M) |
| Capital Expenditures | (2.93M) | (904K) | (6.4M) | (2.24M) | (6.08M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | (125.08M) | (70.49M) |
| Sales of Investments | 0 | 0 | 0 | 148.19M | 55.98M |
| Other Investing Activities | 22.2M | (89.03M) | 25.08M | (103K) | 0 |
| Investing Cash Flow | 19.27M | (89.94M) | 18.68M | 20.77M | (20.59M) |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued | 111K | 3.36M | 49K | 25K | 45.77M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0 | 93.54M | 5.25M | 0 | 0 |
| Financing Cash Flow | 111K | 96.91M | 5.3M | 25K | 45.77M |
| Effect of Forex Changes | 108K | (258K) | 3.1M | 160K | 501K |
| Net Change in Cash | 7.68M | (17.17M) | 9.12M | 1.17M | (1M) |
| Free Cash Flow | (14.74M) | (24.78M) | (24.36M) | (22.02M) | (32.76M) |
Alpha Tau Medical Ltd.
NASDAQ:DRTS
Intrinsic Alpha fair value
Locked
Current Price
$12.01
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.